244 related articles for article (PubMed ID: 8947268)
1. International update: new findings on promising medications.
Litten RZ
Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):216A-218A. PubMed ID: 8947268
[No Abstract] [Full Text] [Related]
2. Alternatives to naltrexone in animal models.
Overstreet DH
Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):231A-235A. PubMed ID: 8947271
[No Abstract] [Full Text] [Related]
3. Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.
Soyka M; Rösner S
Curr Drug Abuse Rev; 2008 Nov; 1(3):280-91. PubMed ID: 19630726
[TBL] [Abstract][Full Text] [Related]
4. Acamprosate.
Mason BJ
Recent Dev Alcohol; 2003; 16():203-15. PubMed ID: 12638639
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
Bouza C; Angeles M; Muñoz A; Amate JM
Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for alcohol dependence: status of current treatments.
Franck J; Jayaram-Lindström N
Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
[TBL] [Abstract][Full Text] [Related]
7. The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field.
Johnson BA; Ait-Daoud N; Roache JD
J Stud Alcohol Suppl; 2005 Jul; (15):157-67; discussion 140. PubMed ID: 16223067
[TBL] [Abstract][Full Text] [Related]
8. [Acamprosate and naltrexone: similar efficacy for relapse].
Saitz R
Rev Med Suisse; 2014 Dec; 10(455):2437. PubMed ID: 25752019
[No Abstract] [Full Text] [Related]
9. [Pharmacological review of alcoholic dependence treatment].
Oural L; Paris MV; Sullivan O; Polach M; Pavlovsky F; Capece J
Vertex; 2008; 19(77):512-21. PubMed ID: 18443665
[TBL] [Abstract][Full Text] [Related]
10. Preserved DNA from past clinical trials yields new information about a subtype of alcoholism.
O'Brien CP
Curr Psychiatry Rep; 2008 Oct; 10(5):375-6. PubMed ID: 18803909
[No Abstract] [Full Text] [Related]
11. Opioid antagonists for the treatment of alcohol dependence.
Yancey JR; Lumbad J
Am Fam Physician; 2011 Nov; 84(9):990-2. PubMed ID: 22046937
[No Abstract] [Full Text] [Related]
12. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.
Soyka M; Chick J
Am J Addict; 2003; 12(s1):s69-s80. PubMed ID: 14972781
[TBL] [Abstract][Full Text] [Related]
13. New pharmacotherapies for alcohol dependence.
Graham R; Wodak AD; Whelan G
Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic approaches to the management of alcoholism.
Anton RF
J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological treatment of alcohol dependence. Acamprosate and naltrexone offer new approach].
Berglund M; Balldin J; Bendtsen P; Borg S; Franck J; Gustafsson L; Halldin J; Månsson M; Nilsson LH; Stolt G; Willander A
Lakartidningen; 1997 Jul; 94(30-31):2645-8. PubMed ID: 9273426
[No Abstract] [Full Text] [Related]
16. Pharmacological treatment of alcohol dependence: a review of the evidence.
Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
Snyder JL; Bowers TG
Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
[TBL] [Abstract][Full Text] [Related]
18. Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators.
Ooteman W; Naassila M; Koeter MW; Verheul R; Schippers GM; Houchi H; Daoust M; van den Brink W
Addict Biol; 2009 Jul; 14(3):328-37. PubMed ID: 19523047
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of recurrent alcoholism with acamprosate. Neurobiological principles and clinical results].
Soyka M; Zieglgänsberger W
Internist (Berl); 1999 Mar; 40(3):330-6. PubMed ID: 10205765
[No Abstract] [Full Text] [Related]
20. Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.
Kiefer F; Jiménez-Arriero MA; Klein O; Diehl A; Rubio G
Addict Biol; 2008 Mar; 13(1):124-9. PubMed ID: 17573782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]